(MedPage Today) — ORLANDO — Researchers identified four predictors of clinically relevant bleeding in patients receiving extended anticoagulation with apixaban (Eliquis) for cancer-associated venous thromboembolism (VTE).
Over a median follow…
Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118933
Author :
Publish date : 2025-12-10 18:27:00
Copyright for syndicated content belongs to the linked Source.














